Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized parallel study of Gualoupi injection for stable angina in coronary heart disease
ChiCTR2100046268Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gualoupi injection in coronary arteriosclerosis and stable angina (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Angina pectoris symptom efficacy and Electrocardiographic efficacy. Started Apr 2020; status: recruiting.
02
Drugs
gualoupi injection
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2100046268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046268.